Vital Proteins’ ‘Timely’ Immunity Product Launch Makes Time Right For Nestle Investment
Nestle Health Science has majority stake in US firm that started offering a powder blend for beverages containing vitamin C, collagen, L glutamine, zinc, electrolytes and beta glucan earlier in 2020, when consumer interest spiked in boosting immunity health.
You may also be interested in...
Nestle agrees to acquire Aimmune Therapeutics, maker of a drug indicated to reduce the severity of children’s allergic reactions to peanuts. It anticipates options to innovate in its consumer health children’s allergy business.
Nestle Health Science acquires IM HealthScience, marketer of medical foods IBgard and FDgard as well as prebiotic and sleep aid supplements. The deal is second recent US consumer health addition for the firm after it said 2020 would be “‘more vigorous” year for acquisitions despite the COVID-19 pandemic.
Otsuka Pharmaceutical Co. subsidiary announces nurish by Nature Made featuring 30-day supplies of vitamin packets delivered to customers after they complete online assessments evaluating core nutrient needs based on age, diet, lifestyle, wellness and general health.